Evidence map›Paper›PMID 22922257›Full record

ArticleThe Journal of clinical investigation2012

C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice.

Pierre Kyme, Nils H Thoennissen, Ching Wen Tseng, Gabriela B Thoennissen, Andrea J Wolf, Kenichi Shimada, Utz O Krug, Kunik Lee, Carsten Müller-Tidow, Wolfgang E Berdel and 4 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. NADAnimal nutrition (Zhongguo xu mu shou yi xue hui) · 2022
    Review
  11. Review
  12. Article
  13. Article
  14. [Inhibitory Effects of Nicotinamide onSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

14 authors at 3 institutions in 4 countries.

Pierre KymeDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. pierre.kyme@gmail.com
Nils H Thoennissen
Ching Wen Tseng
Gabriela B Thoennissen
Andrea J Wolf
Kenichi Shimada
Utz O Krug
Kunik Lee
Carsten Müller-Tidow
Wolfgang E Berdel
W David Hardy
Adrian F Gombart
H Phillip Koeffler
George Y Liu
Cedars-Sinai Medical Center · USUniversity of Münster · DEOregon State University · US

Funding

Training and Mentoring ProgramsU54CA143930 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PIETRAS, RICHARD JOSEPH · 2009 to 2020
$7.5M
REGULATION OF HEMATOPOIETIC CYTOKINESR01CA026038 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KOEFFLER, HAROLD PHILLIP · 1985 to 2013
$4.7M
Regulating Cathelicidin Expression for Disease TherapyR01AI065604 · NIAID · OREGON STATE UNIVERSITY · PI GOMBART, ADRIAN FRIEDRICH · 2007 to 2011
$2.1M
Antioxidant-based mechanisms used by staphyloccocus aureus to evade host defensesR01AI074832 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI LIU, GEORGE Y · 2007 to 2010
$1.6M
NCI NIH HHS R01 CA026038NCI NIH HHS R01 CA026038-30NCI NIH HHS U54 CA143930NCI NIH HHS U54 CA143930-01NIAID NIH HHS R01 AI065604NIAID NIH HHS R01 AI065604-05NIAID NIH HHS R01 AI074832
6 · The paper itself

Abstract

The myeloid-specific transcription factor, CCAAT/enhancer-binding protein ε (C/EBPε) is a critical mediator of myelopoiesis. Mutation of this gene is responsible for neutrophil-specific granule deficiency in humans, a condition that confers susceptibility to Staphylococcus aureus infection. We found that C/EBPε-deficient mice are severely affected by infection with S. aureus, and C/EBPε deficiency in neutrophils contributes to the infectious phenotype. Conversely, exposure to the epigenetic modulator nicotinamide (vitamin B3) increased expression of C/EBPε in WT myeloid cells. Further, nicotinamide increased the activity of C/EBPε and select downstream antimicrobial targets, particularly in neutrophils. In a systemic murine infection model as well as in murine and human peripheral blood, nicotinamide enhanced killing of S. aureus by up to 1,000 fold but had no effect when administered to either C/EBPε-deficient mice or mice depleted of neutrophils. Nicotinamide was efficacious in both prophylactic and therapeutic settings. Our findings suggest that C/EBPε is an important target to boost killing of bacteria by the innate immune system.

Indexed as

AcetylationAnimalsAnti-Bacterial AgentsCCAAT-Enhancer-Binding ProteinsCells, CulturedGene ExpressionGene Expression RegulationHistonesHumansImmunity, InnateMacrophagesMiceMice, KnockoutMicrobial ViabilityNeutrophilsNiacinamideAnti-Bacterial AgentsCCAAT-Enhancer-Binding ProteinsCebpe protein, mouseHistonesNiacinamide

Identifiers

PMID22922257
PMCPMC3428083
OpenAlexW2073290395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.